Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Dec;51(12):4276-83.
doi: 10.1128/AAC.00830-07. Epub 2007 Sep 24.

Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin

Affiliations

Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin

Michelle D Brazas et al. Antimicrob Agents Chemother. 2007 Dec.

Abstract

With few novel antimicrobials in the pharmaceutical pipeline, resistance to the current selection of antibiotics represents a significant therapeutic challenge. Microbial persistence in subinhibitory antibiotic environments has been proposed to contribute to the development of resistance. Pseudomonas aeruginosa cultures pretreated with subinhibitory concentrations of ciprofloxacin were found to exhibit an adaptive resistance phenotype when cultures were subsequently exposed to suprainhibitory ciprofloxacin concentrations. Microarray experiments revealed candidate genes involved in such adaptive resistance. Screening of 10,000 Tn5-luxCDABE mutants identified several mutants with increased or decreased ciprofloxacin susceptibilities, including mutants in PA1803, a close homolog of the ATP-dependent lon protease, which were found to exhibit > or = 4-fold-increased susceptibilities to ciprofloxacin and other fluoroquinolones, but not to gentamicin or imipenem, as well as a characteristic elongated morphology. Complementation of the lon mutant restored wild-type antibiotic susceptibility and cell morphology. Expression of the lon mutant, as monitored through a luciferase reporter fusion, was found to increase over time in the presence of subinhibitory ciprofloxacin concentrations. The data are consistent with the hypothesis that the induction of Lon by ciprofloxacin is involved in adaptive resistance.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Survival ability of P. aeruginosa in ciprofloxacin at 2× MIC following growth in subinhibitory concentrations of ciprofloxacin. Cultures of P. aeruginosa strain H103 were grown in the presence (□, 0.01 μg/ml; ▵, 0.03 μg/ml) or absence (⧫) of subinhibitory concentrations of ciprofloxacin to mid-logarithmic phase; then they were washed and exposed to 0.2 μg/ml ciprofloxacin. CFU were counted every 15 min for 2 h. Results from a representative data set of four independent experiments are shown.
FIG. 2.
FIG. 2.
Percentage of genes in each of the gene functional categories exhibiting expression changes after growth of P. aeruginosa in subinhibitory and inhibitory concentrations of ciprofloxacin. A.A., amino acid; FA, fatty acid.
FIG. 3.
FIG. 3.
Induction of the lon::luxCDABE fusion (H1105) with 0.3× MIC ciprofloxacin (shaded bars) over expression in untreated H1105 cultures (open bars). Results are modes from four independent experiments.
FIG. 4.
FIG. 4.
Gram-stained P. aeruginosa strains grown for 3 h in the presence or absence of subinhibitory ciprofloxacin concentrations. As evident from the Gram stain images of cells grown in the absence or presence of 0.3× MIC ciprofloxacin [0.03 μg/ml for H103 and H1105/lon+; 0.0075 μg/ml for H1105 (lon::lux)], cell division of P. aeruginosa mutants with alterations in the Lon protease homolog [H1105 (lon::lux)] was inhibited relative to that of wild-type H103 cells. Complementation of the lon mutant (H1105/lon+) restored cell division. All micrographs are at ×1,000 magnification.

Similar articles

Cited by

References

    1. Abella, M., I. Erill, M. Jara, G. Mazon, S. Campoy, and J. Barbe. 2004. Widespread distribution of a lexA-regulated DNA damage-inducible multiple gene cassette in the Proteobacteria phylum. Mol. Microbiol. 54:212-222. - PubMed
    1. Amsterdam, D. 1991. Susceptibility testing of antimicrobials in liquid media, p. 72-78. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, MD.
    1. Bandow, J. E., H. Brotz, L. I. Leichert, H. Labischinski, and M. Hecker. 2003. Proteomic approach to understanding antibiotic action. Antimicrob. Agents Chemother. 47:948-955. - PMC - PubMed
    1. Baquero, F. 2001. Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist. Updat. 4:93-105. - PubMed
    1. Barclay, M. L., E. J. Begg, S. T. Chambers, P. E. Thornley, P. K. Pattemore, and K. Grimwood. 1996. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. J. Antimicrob. Chemother. 37:1155-1164. - PubMed

Publication types

MeSH terms

LinkOut - more resources